Biblio

Export 1008 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Keyword is C  [Clear All Filters]
Journal Article
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C., An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease., Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
C. Lange, Suppa, P., Frings, L., Brenner, W., Spies, L., and Buchert, R., Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion., J Alzheimers Dis, vol. 49, no. 4, pp. 945-59, 2016.
S. Lim, Choi, J. Gyu, Moon, M., Kim, H. Geun, Lee, W., Bak, H. - R., Sung, H., Park, C. Hye, Kim, S. Yeou, and Oh, M. Sook, An Optimized Combination of Ginger and Peony Root Effectively Inhibits Amyloid-β Accumulation and Amyloid-β-Mediated Pathology in AβPP/PS1 Double-Transgenic Mice., J Alzheimers Dis, vol. 50, no. 1, pp. 189-200, 2016.
V. Panzarella, Mauceri, R., Baschi, R., Maniscalco, L., Campisi, G., and Monastero, R., Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project., J Alzheimers Dis, vol. 87, no. 1, pp. 173-183, 2022.
V. Panzarella, Mauceri, R., Baschi, R., Maniscalco, L., Campisi, G., and Monastero, R., Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project., J Alzheimers Dis, vol. 87, no. 1, pp. 173-183, 2022.
V. Panzarella, Mauceri, R., Baschi, R., Maniscalco, L., Campisi, G., and Monastero, R., Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project., J Alzheimers Dis, vol. 87, no. 1, pp. 173-183, 2022.
M. L. Croze and Zimmer, L., Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms., J Alzheimers Dis, vol. 62, no. 2, pp. 503-522, 2018.
G. Marwarha, Rostad, S., Lilek, J., Kleinjan, M., Schommer, J., and Ghribi, O., Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation., J Alzheimers Dis, vol. 57, no. 3, pp. 907-925, 2017.
S. Beggiato, Borelli, A. Celeste, Ferraro, L., Tanganelli, S., Antonelli, T., and Tomasini, M. Cristina, Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures., J Alzheimers Dis, vol. 61, no. 1, pp. 389-399, 2018.
S. Beggiato, Borelli, A. Celeste, Ferraro, L., Tanganelli, S., Antonelli, T., and Tomasini, M. Cristina, Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures., J Alzheimers Dis, vol. 61, no. 1, pp. 389-399, 2018.
S. Beggiato, Borelli, A. Celeste, Ferraro, L., Tanganelli, S., Antonelli, T., and Tomasini, M. Cristina, Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures., J Alzheimers Dis, vol. 61, no. 1, pp. 389-399, 2018.
S. Beggiato, Borelli, A. Celeste, Ferraro, L., Tanganelli, S., Antonelli, T., and Tomasini, M. Cristina, Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures., J Alzheimers Dis, vol. 61, no. 1, pp. 389-399, 2018.
A. Gabelle, Gutierrez, L. - A., Dartigues, J. - F., Ritchie, K., Touchon, J., and Berr, C., Palmomental Reflex a Relevant Sign in Early Alzheimer's Disease Diagnosis?, J Alzheimers Dis, vol. 49, no. 4, pp. 1135-41, 2016.
J. J. Iliff, Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., G Vates, E., Deane, R., Goldman, S. A., Nagelhus, E. A., and Nedergaard, M., A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β., Sci Transl Med, vol. 4, no. 147, p. 147ra111, 2012.
J. J. Iliff, Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., G Vates, E., Deane, R., Goldman, S. A., Nagelhus, E. A., and Nedergaard, M., A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β., Sci Transl Med, vol. 4, no. 147, p. 147ra111, 2012.
N. Voyle, Keohane, A., Newhouse, S., Lunnon, K., Johnston, C., Soininen, H., Kloszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Lovestone, S., Hodges, A., Kiddle, S., and Dobson, R. Jb, A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis., J Alzheimers Dis, vol. 49, no. 3, pp. 659-69, 2016.
N. Y. Kirson, J Andrews, S., Desai, U., King, S. B., Schonfeld, S., Birnbaum, H. G., Ball, D. E., and Kahle-Wrobleski, K., Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 295-307, 2018.
N. Y. Kirson, J Andrews, S., Desai, U., King, S. B., Schonfeld, S., Birnbaum, H. G., Ball, D. E., and Kahle-Wrobleski, K., Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 295-307, 2018.
K. Sakai, Senda, T., Hata, R., Kuroda, M., Hasegawa, M., Kato, M., Abe, M., Kawaguchi, K., Nakai, S., Hiki, Y., Yuzawa, Y., and Kitaguchi, N., Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid., J Alzheimers Dis, vol. 51, no. 4, pp. 997-1002, 2016.
Y. Moon, Han, S. - H., and Moon, W. - J., Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging., J Alzheimers Dis, vol. 51, no. 3, pp. 737-45, 2016.
L. - S. Liu, Bai, X. - Q., Gao, Y., Wu, Q., Ren, Z., Li, Q., Pan, L. - H., He, N. - Y., Peng, J., and Tang, Z. - H., PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling Pathway., J Alzheimers Dis, vol. 57, no. 3, pp. 723-734, 2017.
L. - S. Liu, Bai, X. - Q., Gao, Y., Wu, Q., Ren, Z., Li, Q., Pan, L. - H., He, N. - Y., Peng, J., and Tang, Z. - H., PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling Pathway., J Alzheimers Dis, vol. 57, no. 3, pp. 723-734, 2017.
A. F. Teich, Sakurai, M., Patel, M., Holman, C., Saeed, F., Fiorito, J., and Arancio, O., PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease., J Alzheimers Dis, vol. 52, no. 1, pp. 295-302, 2016.
L. Wang, Chen, H., Tang, J., Guo, Z., and Wang, Y., Peptidylarginine Deiminase and Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 473-484, 2022.
L. Wang, Chen, H., Tang, J., Guo, Z., and Wang, Y., Peptidylarginine Deiminase and Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 473-484, 2022.

Pages